J1840 HCPCS Level II code: Injection, kanamycin sulfate, up to 500 mg
CMS terminated J1840: its last date of service was Mar 31, 2024. It stays here for looking up older claims; newer services need a current code.
Official description
J1840Injection, kanamycin sulfate, up to 500 mg
Short description: Kanamycin sulfate 500 mg inj
HCPCS · United States
Medicare details
The indicators CMS publishes with J1840 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
- Terminated after
- Mar 31, 2024
Where J1840 sits
- 1J codesDrugs administered other than orally
- 2Terminated J1840Injection, kanamycin sulfate, up to 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J1840 still valid?
No. CMS terminated J1840; its last date of service was Mar 31, 2024. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J1840?
CMS lists J1840’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1840
All J codesJ1830Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self…J1833Injection, isavuconazonium, 1 mgJ1834Injection, isoniazid, 1 mgJ1835Injection, itraconazole, 50 mgJ1836Injection, metronidazole, 10 mgJ1837Injection, posaconazole, 1 mgJ1850Injection, kanamycin sulfate, up to 75 mgJ1885Injection, ketorolac tromethamine, per 15 mgJ1890Injection, cephalothin sodium, up to 1 gramJ1920Injection, labetalol hydrochloride, 5 mgJ1921Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mgJ1930Injection, lanreotide, 1 mg